Starbucks is cutting GLP-1 coverage for weight loss as employer costs climb

Starbucks will stop covering the GLP-1 drugs for weight loss, adding to a broader employer retreat from an increasingly costly benefit.

venerdì 7 agosto 2026 New tab

622 words~3 min read

Exclusive

By

Sarah E. Needleman

You're currently following this author!

Want to unfollow? Unsubscribe via the link in your email.

Other newsrooms on this story

· 3 sources

· 3 sources

Starbucks has announced that it will stop covering the GLP-1 medications prescribed for weight loss under its employee health…

timesofindia.indiatimes.com17 h fa

Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34%…

cnbc.com1 mese fa

Companies have “tremendous concern” about the financial viability of these medications, the president and CEO of the Business…

hrdive.com3 mesi fa

More employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the…

statnews.com2 mesi fa

Cost remains a major factor for employers as the popular drug for weight loss represented 11.4% of annual claims for corporations…

hrdive.com25 g fa

Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss…

forbes.com2 mesi fa